Subsequent Events

9 Months Ended

Sep. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On October 30, 2020, Digirad entered into a Stock Purchase Agreement (the “ DMS Purchase Agreement”) by and among Digirad, Project Rendezvous Acquisition Corporation, a Delaware corporation and wholly owned subsidiary of Digirad (“Seller”), DMS Health Technologies, Inc., a North Dakota corporation and wholly owned subsidiary of Seller (“DMS Health”), and Knob Creek Acquisition Corp., a Tennessee corporation (“Buyer”) pursuant to which, subject to the satisfaction or waiver of certain conditions, Buyer will purchase all of the issued and outstanding common stock of DMS Health from Seller (the “ DMS Sale Transaction”). The purchase price for the DMS Sale Transaction is $18.75 million in cash, subject to certain adjustments, including a working capital adjustment. The completion of the DMS Sale Transaction is subject to receipt of certain consents and customary closing conditions. The DMS Sale Transaction is not subject to approval by the Company’s stockholders. Assuming the satisfaction or waiver of the closing conditions, the DMS Sale Transaction is expected to close on or about January 4, 2021.

For additional information on the above subsequent events see the Company's Current Report on Form 8-K filed with the SEC on November 3, 2020.